Disclosure Of Entity's Operating Segments [Text Block]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
GBP
200,000 GBP
Interest income
GBP
1,469 GBP
Interest expense
44,857 GBP
58 GBP
Tax expense (income)
242,766 GBP
187,693 GBP
Profit (loss) before tax
1,214,569 GBP
1,932,233 GBP
Profit (loss)
971,803 GBP
GBP
GBP
GBP
GBP
GBP
971,803 GBP
GBP
1,744,540 GBP
GBP
GBP
GBP
1,744,540 GBP
GBP
Assets
5,750,745 GBP
6,088,568 GBP
Liabilities
861,726 GBP
589,025 GBP
Cash flows from (used in) operating activities
783,731 GBP
1,733,533 GBP
Cash flows from (used in) investing activities
GBP
52,573 GBP
Cash flows from (used in) financing activities
584,915 GBP
58 GBP
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.